IGF1 and colorectal cancer: The emerging research on colorectal cancer risk for people with diabetes suggests that diabetic patients with poor glycemic control may have even higher risk because they exhibit high levels of circulating insulin and IGF-1 and are often receiving multiple treatments (21-25).